Granahan Investment Management, LLC Insmed Inc Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

A detailed history of Granahan Investment Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Granahan Investment Management, LLC holds 217,345 shares of INSM stock, worth $16 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

217,345

Previous 259,275 16.17%

Holding current value

$16 Million

Previous $17.4 Million 8.66%

% of portfolio

0.67%

Previous 0.73%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $2.6 Million - $3.31 Million	-41,930 Reduced 16.17%	217,345 $15.9 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $2.76 Million - $8.75 Million	125,520 Added 93.84%	259,275 $17.4 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $1.76 Million - $2.05 Million	-68,438 Reduced 33.85%	133,755 $3.63 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $791,291 - $1.07 Million	-33,787 Reduced 14.32%	202,193 $6.27 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $887,682 - $1.2 Million	-44,697 Reduced 15.92%	235,980 $5.96 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $271,046 - $347,875	16,487 Added 6.24%	280,677 $5.92 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $881,828 - $1.18 Million	54,233 Added 25.83%	264,190 $4.5 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $3.57 Million - $4.86 Million	209,957 New	209,957 $4.19 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $5.87 Million - $8.84 Million	-343,877 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $780,329 - $1.07 Million	38,214 Added 12.5%	343,877 $8.08 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $27,624 - $35,691	-1,067 Reduced 0.35%	305,663 $8.33 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $2.37 Million - $3.12 Million	-105,723 Reduced 25.63%	306,730 $8.45 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $2.15 Million - $3.2 Million	88,994 Added 27.51%	412,453 $11.7 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $791,570 - $1.09 Million	-24,522 Reduced 7.05%	323,459 $11 Million
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $2.1 Million - $2.71 Million	-66,863 Reduced 16.12%	347,981 $11.6 Million
Q3 2020 Nov 12, 2020	SELL	$26.0 - $34.5 $1.53 Million - $2.03 Million	-58,921 Reduced 12.44%	414,844 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $996,024 - $2.08 Million	70,590 Added 17.51%	473,765 $13 Million
Q1 2020 May 12, 2020	SELL	$13.63 - $33.98 $2.46 Million - $6.13 Million	-180,542 Reduced 30.93%	403,175 $6.46 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $1.01 Million - $1.57 Million	62,748 Added 12.04%	583,717 $13.9 Million
Q3 2019 Nov 15, 2019	BUY	$15.49 - $25.78 $4.74 Million - $7.89 Million	305,989 Added 142.33%	520,969 $9.19 Million
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $319,010 - $446,475	-13,870 Reduced 6.06%	214,980 $5.5 Million
Q1 2019 May 14, 2019	BUY	$13.91 - $31.15 $3.18 Million - $7.13 Million	228,850 New	228,850 $6.65 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.94B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account

Granahan Investment Management, LLC Insmed Inc Transaction History